Symphony Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.07M Buy
6,597
+254
+4% +$260K 0.88% 30
2026
Q1
$5.79M Buy
6,343
+340
+6% +$345K 0.77% 37
2025
Q4
$6.48M Sell
6,003
-199
-3% -$190K 0.87% 31
2025
Q3
$4.79M Sell
6,202
-10,824
-64% -$8.05M 0.58% 45
2025
Q2
$4.38M Buy
17,026
+14,602
+602% +$11.3M 0.57% 47
2025
Q1
$2M Sell
2,424
-2,365
-49% -$1.97M 1.18% 21
2024
Q4
$3.58M Sell
4,789
-480
-9% -$397K 0.56% 48
2024
Q3
$4.64M Buy
5,269
+432
+9% +$388K 0.77% 35
2024
Q2
$4.38M Buy
4,837
+1,753
+57% +$1.4M 0.8% 36
2024
Q1
$2.4M Sell
3,084
-1,275
-29% -$907K 0.56% 45
2023
Q4
$2.76M Buy
4,359
+1,323
+44% +$772K 0.59% 43
2023
Q3
$1.63M Sell
3,036
-1,146
-27% -$591K 0.4% 49
2023
Q2
$1.94M Sell
4,182
-419
-9% -$176K 0.48% 50
2023
Q1
$1.57M Buy
4,601
+3,230
+236% +$1.09M 0.41% 54
2022
Q4
$498K Sell
1,371
-256
-16% -$90.8K 0.13% 139
2022
Q3
$537K Sell
1,627
-47
-3% -$14.9K 0.18% 126
2022
Q2
$541K Sell
1,674
-56
-3% -$16.8K 0.16% 123
2022
Q1
$533K Buy
1,730
+403
+30% +$104K 0.13% 122
2021
Q4
$361K Buy
1,327
+145
+12% +$36.8K 0.1% 130
2021
Q3
$272K Sell
1,182
-119
-9% -$29.4K 0.09% 148
2021
Q2
$299K Sell
1,301
-593
-31% -$119K 0.1% 138
2021
Q1
$346K Buy
+1,894
New +$370K 0.09% 139

Other funds holding LLY

Symphony Financial's LLY Position: Q2 2026 in Review

Symphony Financial increased its Eli Lilly (LLY) stake by 4% in Q2 2026, buying an estimated $260K and bringing the position to 6,597 shares worth $8.07M. The position accounts for 0.88% of the portfolio, ranked #30.

Symphony Financial first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Symphony Financial held 6,597 shares of Eli Lilly worth $8.07M as of Q2 2026.
  • Symphony Financial bought 254 Eli Lilly shares in Q2 2026, an estimated $260K.
  • Eli Lilly made up 0.88% of Symphony Financial's portfolio in Q2 2026, its #30 holding.
  • Symphony Financial first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Symphony Financial's 13F filing for Q2 2026, filed 4 Aug 2026.